Interne link ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor september 23, 2026 om 12:00 PM UTC
Interne link ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 september 09, 2026 om 12:00 PM UTC
Interne link ProQR to Participate in Upcoming Investor Conferences in September 2026 september 02, 2026 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2026 Operating and Financial Results augustus 13, 2026 om 11:00 AM UTC
Interne link ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement juni 25, 2026 om 10:35 AM UTC
Interne link ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform juni 25, 2026 om 10:25 AM UTC
Interne link ProQR Announces First Quarter 2026 Operating and Financial Results mei 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform mei 11, 2026 om 12:00 PM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 mei 04, 2026 om 12:00 PM UTC
Interne link ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors april 30, 2026 om 12:00 PM UTC
Interne link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event april 08, 2026 om 08:00 PM UTC
Interne link ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board april 08, 2026 om 12:00 PM UTC
Interne link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 maart 25, 2026 om 12:00 PM UTC
Interne link ProQR Announces Year End 2025 Operating and Financial Results maart 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference maart 03, 2026 om 09:30 PM UTC
Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook januari 08, 2026 om 01:00 PM UTC
Interne link ProQR to Participate in 8th Annual Evercore Healthcare Conference december 01, 2025 om 01:00 PM UTC
Interne link ProQR Announces Third Quarter 2025 Operating and Financial Results november 06, 2025 om 12:00 PM UTC
Interne link ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 oktober 20, 2025 om 12:00 PM UTC
Interne link ProQR to Participate in Upcoming Investor Conferences in October 2025 oktober 13, 2025 om 12:30 PM UTC
Interne link ProQR Announces Second Quarter 2025 Operating and Financial Results augustus 07, 2025 om 11:00 AM UTC
Interne link ProQR Announces Upcoming Presentation at RNA Editing Summit juli 28, 2025 om 12:00 PM UTC
Interne link ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP juni 26, 2025 om 08:30 PM UTC
Interne link ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences mei 12, 2025 om 12:00 PM UTC